Table 2.

Cox regression analysis for overall survival (multivariable analysis) in patients analyzed for LKB1 protein expression

Patients (N = 98)Events (N = 81)HR (95% CI)P
PS (ECOG)0.0315
 036261a
 1, 262551.76 (1.05–2.95)
First-line treatment0.6803
LKB1 status IHC0.0297
LKB1 negative/weak
 No bevacizumab vs. bevacizumab1.12 (0.64–1.97)0.6803
LKB1 moderate/intense
 No bevacizumab vs. bevacizumab3.84 (1.56–9.48)0.0035
  • aReference category.